The Oncology 2 Unit provides chemotherapy, immunotherapy and target cancer therapies for patients suffering from breast, lung, thymic, gynecologic, and head and neck cancers. Patients are treated following standardized protocols or they may be enrolled in clinical trials.

The Unit uses a multidisciplinary approach to guarantee the best possible treatment pathway to each patient. Also, patients are cared for in a shared and continuous manner by the various specialists of the multidisciplinary team. The treatment strategy is established during the first outpatient visit or in specific outpatient clinics, in the collaboration with the other units of the IOV and the Hospital Company-University of Padua.

The Unit integrates clinical and preclinical research in cancer care to optimize treatment for patients who are candidates for innovative drugs and integrated approaches.

The conditions treated in this unit include: cervical cancer, endometrial cancer, mesothelioma, neuroendocrine cancers, ovarian cancer, lung cancer, breast cancer, head and neck cancer, and vulvar cancer.

Direttore della struttura

Prof. PierFranco Conte

PierFranco Conte is Full Professor of Oncology at the University of Padova and Director of the Division of Medical Oncology 2 at the Istituto Oncologico Veneto in Padova. He specialized in Clinical Oncology, Clinical Immunology and Hematology. Throughout his career, Prof. Conte has been involved in the development of new regimens for the treatment of[.....] Leggi tutto